Previous studies have shown that SLAMF5 facilitates interactions between chronic lymphocytic leukemia (CLL) cells and their microenvironment, promoting CLL cell survival and suppressing T cell activity through upregulation of PD-L1 [33–35]. The gene discussed is CD84; the disease is B-cell chronic lymphocytic leukemia.